Standard Biotools Inc. (NASDAQ: LAB) related to its merger with Treeline Biosciences, Inc. Upon closing of the proposed transaction, Standard Biotools shareholders are expected to own approximately 16% of the combined company.
Standard Biotools Inc. (NASDAQ: LAB) related to its merger with Treeline Biosciences, Inc. Upon closing of the proposed transaction, Standard Biotools shareholders are expected to own approximately 16% of the combined company.